Ngeugoue Francois Tchokouaha, Njoumemi Zachariaou, Kaze Francois Folefack
Clin Nephrol. 2020 Supplement-Jan;93(1):100-102. doi: 10.5414/CNP92S117.
Chronic kidney disease (CKD) affects ~ 10% of the world population. In most developing nations, the costs for the treatment of CKD are met by patients. Data on the economic burden of early stages of CKD are scarce; few studies have evaluated the cost of management of CKD stages 3 - 5 in non-dialysis (ND) patients in an out-of-pocket expenditure system. This study estimated the direct, indirect, and global economic cost of management of CKD stages 3 - 5 ND patients in Yaoundé, Cameroon. It was 1-month retrospective cost analysis. Sampling was consecutive and exhaustive of CKD 3 - 5 ND patients. We evaluated direct medical, direct non-medical, and indirect costs. 69 patients were included in the study, and the mean age was 55 years. The median monthly salary of the population was USD 162. Only 1.4% of patients had 100% health insurance coverage. The total cost of management was ~ USD 163. Direct medical, direct non-medical, and indirect costs accounted for 86.4%, 7.1%, and 6.3%, respectively. That global cost was prohibitive to Cameroonians and was tantamount to 2.7 times the minimal wage in Cameroon.
慢性肾脏病（CKD）影响着全球约10%的人口。在大多数发展中国家，CKD的治疗费用由患者承担。关于CKD早期经济负担的数据稀缺；很少有研究在自付费用体系中评估非透析（ND）患者CKD 3 - 5期的管理成本。本研究估算了喀麦隆雅温得CKD 3 - 5期ND患者管理的直接、间接和总体经济成本。这是一项为期1个月的回顾性成本分析。对CKD 3 - 5期ND患者进行连续且全面的抽样。我们评估了直接医疗、直接非医疗和间接成本。69名患者纳入研究，平均年龄为55岁。人群月工资中位数为162美元。仅有1.4%的患者拥有100%的医疗保险覆盖。管理总成本约为163美元。直接医疗、直接非医疗和间接成本分别占86.4%、7.1%和6.3%。该总体成本对喀麦隆人来说过高，相当于喀麦隆最低工资的2.7倍。
